Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What should we hope to achieve when treating rheumatoid arthritis?

Literature DB >> 2649028

What should we hope to achieve when treating rheumatoid arthritis?

D L Scott¹, T D Spector, T Pullar, B McConkey.

Abstract

Entities: Disease

Mesh：

Year: 1989 PMID： 2649028 PMCID： PMC1003733 DOI： 10.1136/ard.48.3.256

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

23 in total

1. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors: J LANSBURY
Journal: Arthritis Rheum Date: 1958-12

2. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors: A Larsen; K Dale; M Eek
Journal: Acta Radiol Diagn (Stockh) Date: 1977-07

Review 3. Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?

Authors: R D Situnayake
Journal: Br J Rheumatol Date: 1988

4. Radiographic evaluation of the course of articular disease.

Authors: J T Sharp
Journal: Clin Rheum Dis Date: 1983-12

5. Toward an understanding of patient outcome measurement.

Authors: J F Fries
Journal: Arthritis Rheum Date: 1983-06

6. Cause of death in rheumatoid arthritis.

Authors: P Prior; D P Symmons; D L Scott; R Brown; C F Hawkins
Journal: Br J Rheumatol Date: 1984-05

7. Long-term outcome of treating rheumatoid arthritis: results after 20 years.

Authors: D L Scott; D P Symmons; B L Coulton; A J Popert
Journal: Lancet Date: 1987-05-16 Impact factor: 79.321

8. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations.

Authors: Y S Sherrer; D A Bloch; D M Mitchell; S H Roth; F Wolfe; J F Fries
Journal: J Rheumatol Date: 1987-08 Impact factor: 4.666

9. Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors: R S Pinals; A T Masi; R A Larsen
Journal: Arthritis Rheum Date: 1981-10

10. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors: R K Mallya; B E Mace
Journal: Rheumatol Rehabil Date: 1981-02-01

14 in total

1. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

Authors: C H van Jaarsveld; J W Jacobs; M J van der Veen; A A Blaauw; A A Kruize; D M Hofman; H L Brus; G A van Albada-Kuipers; A H Heurkens; E J ter Borg; H C Haanen; C van Booma-Frankfort; Y Schenk; J W Bijlsma
Journal: Ann Rheum Dis Date: 2000-06 Impact factor: 19.103

What should we hope to achieve when treating rheumatoid arthritis?

1. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

2. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Review 3. Can 'disease modifying' drugs influence outcome in rheumatoid arthritis?

4. Radiographic evaluation of the course of articular disease.

5. Toward an understanding of patient outcome measurement.

6. Cause of death in rheumatoid arthritis.

7. Long-term outcome of treating rheumatoid arthritis: results after 20 years.

8. Disability in rheumatoid arthritis: comparison of prognostic factors across three populations.

9. Preliminary criteria for clinical remission in rheumatoid arthritis.

10. The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

1. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.

2. Response criteria for slow acting antirheumatic drugs.

Review 3. Measuring performance in clinical rheumatology.

Review 4. Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

5. Can we develop simple response criteria for slow acting antirheumatic drugs?

Review 6. Sex hormones and the risk of osteoarthritis in women: epidemiological evidence.

7. Disease remission in rheumatoid arthritis.

8. Disease assessment in rheumatoid arthritis.

9. Evaluating drugs in rheumatoid arthritis.

10. Assessment of rheumatoid arthritis.